動物医療用バイオ技術/クローニング/遺伝学

Overview:

Recent advances in biotechnology, cloning and genetics have made possible a wide range of new technologies and products. Over the next decade these may revolutionise both commercial livestock production and the companion animal sector. This Animal Pharm report is the first to identify the commercial potential of these new technologies.

Key features of the report

An analysis of advances in four key industry sectors:

• transgenic animals, cloning and genomic sequencing
• therapies using bacteriophages, monoclonal antibodies, stem cells and therapeutic proteins vaccines, including plant-based and DNA vaccines
• diagnostics, including tests for BSE, trace back of food and inherited diseases

Each of these sections identifies the leading companies and their technologies; the commercial potential of the developments; and the technical and commercial constraints that must be overcome

• A review of the structure of the animal biotechnology industry, identifying the key players and the partnerships that have developed between the major animal health multinationals and the R&D-focused start-ups
• 67 profiles of the leading academic and government research institutions and commercial companies at the cutting edge of animal biotechnology R&D, allowing you to identify potential R&D partners, or your competitors in developing the technologies of the future
• An easy-to-understand introduction to the technical background to the new industry and a glossary of key terms, making this report accessible to specialists and non-specialists alike
• An analysis of the key issues in terms of regulations and public acceptance, allowing you to judge the commercial potential of new technologies and products
• More than 150 academic and business references, allowing you to further investigate the key research that has been identified.

Executive Summary:

This report covers the new opportunities in animal health created by biotechnology, including transgenic animals and cloning, genome sequencing, genetic testing, recombinant proteins and vaccines. The science is put in the context of commercial opportunities for applications of scientific breakthroughs to develop new products for animal health.

In order to understand the technology and its commercial potential, the history of biotech products for animal health is reviewed, including background on the drugs and vaccines that have been approved worldwide. The regulatory issues raised by these new technologies, and how the regulators are approaching transgenic and cloned animals and their products is reviewed, with the latest information through the end of 2003.

Summary table of contents

Chapter 1 Biotechnology Introduction and Definitions (6 pages)

History of the development of animal health products

Biotechnology products on the market

Chapter2  The Market and Industry in Context (18 pages)

Regulatory issues

Public acceptance

Industry structure

Chapter 3 Transgenic Animals and Cloning (32 pages)

Livestock with improved traits

Livestock producing products for human health

Companion animals

Genomic sequencing

Microorganism and parasite drug target identification

Chapter 4  Therapies of the Future (20 pages)

Vaccines to treat cancer

Bacteriophages

Monoclonal antibodies

Therapeutic proteins

Gene therapy

Novel approaches

Chapter 5  Vaccines of the Future (20 pages)

Genetically engineered vaccines

DNA vaccines

Improved adjuvant and delivery technology

Plant-based vaccines

Licensing deals, M&As

Chapter 6  Diagnostics of the Future (24 pages)

Genetic tests to aid breeding management

Disease diagnostics

Trace back of food products

Chapter 7  Companies,Academia and Government Institutions (66 pages)

Profiles of 25 academic and government research institutions and 42 commercial companies involved in animal genetics and biotechnology References 8 pages of academic and commercial references